Immunogenicity of Covid-19 Vaccination in Subjects with Myelodysplastic Syndromes

Myelodysplastic syndromes (MDS) represent a spectrum of clonal bone marrow neoplasms from low risk disease through to those transforming into acute myeloid leukaemia. The COVID-19 pandemic has presented a great risk to those with hematological malignancies who are at higher risk of severe disease an...

Descripción completa

Detalles Bibliográficos
Autores principales: Vidler, Jennifer, Alaguthurai, Thanussuyah, Abdul-Jawad, Sultan, Viramuthu, Sivalekha, Beatson, Richard, Graham, Rosalind, Irshad, Sheeba, Kulasekararaj, Austin G., Patten, Piers EM
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology. Published by Elsevier Inc. 2021
Materias:
637.Myelodysplastic Syndromes - Clinical and Epidemiological
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701416/
http://dx.doi.org/10.1182/blood-2021-152401

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701416/
http://dx.doi.org/10.1182/blood-2021-152401

Ejemplares similares